Therapy Optimisation for the Treatment of Hairy Cell Leukemia
מצבים רפואיים
Hairy Cell Leukemia
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
Community based hemato-oncology medical office, Ansbach, Germany
Contact: Study coordinator (Sebastian Müller, PhD)Contact: Principal Investigator (Sebastian Müller, PhD)Community based hemato-oncology medical office, Aschaffenburg, Germany
Contact: Study coordinator (Manfred Welslau, PhD)Contact: Principal Investigator (Manfred Welslau, PhD)Rhön-Saale-Klinik gGmbH, Bad Neustadt an der Saale, Germany
Contact: Study coordinator (Klaus Wutke, PhD)Contact: Principal Investigator (Klaus Wutke, PhD)Community based hemato-oncology medical office, Berlin, Germany
Contact: Study coordinator (Herbert Lebahn, PhD)Contact: Principal Investigator (Herbert Lebahn, PhD)Charité - Universitätsmedizin Berlin, Berlin, Germany
Contact: Study coordinator (Eckhard Thiel, Prof PhD)Contact: Principal Investigator (Eckhard Thiel, Prof PhD)Community based hemato-oncology medical office, Bremen, Germany
Contact: Study coordinator (Karl Wietholt, PhD)Contact: Principal Investigator (Karl Wietholt, PhD)Community based hemato-oncology medical office, Celle, Germany
Contact: Study coordinator (Felix Marquard, PhD)Contact: Principal Investigator (Felix Marquard, PhD)Community based hemato-oncology medical office, Cottbus, Germany
Contact: Study coordinator (Ulrich von Grünhagen, PhD)Contact: Principal Investigator (Ulrich von Grünhagen, PhD)Community based hemato-oncology medical office, Darmstadt, Germany
Contact: Study coordinator (Georgi Kojouharoff, PhD)Contact: Principal Investigator (Georgi Kojouharoff, PhD)Community based hemato-oncology medical office, Dresden, Germany
Contact: Study coordinator (Steffen Dörfel, PhD)Contact: Principal Investigator (Steffen Dörfel, PhD)Community based hemato-oncology medical office, Duisburg, Germany
Contact: Study coordinator (Johannes Selbach, PhD)Contact: Principal Investigator (Johannes Selbach, PhD)Klinik Duisburg-West, Duisburg, Germany
Contact: Study coordinator (Rüdiger Lang, PhD)Contact: Principal Investigator (Rüdiger Lang, PhD)Universitätsklinik Düsseldorf, Düsseldorf, Germany
Contact: Study coordinator (Guido Kobbe, PhD)Contact: Principal Investigator (Guido Kobbe, PhD)Community based hemato-oncology medical office, Ehingen, Germany
Contact: Study coordinator (Martin Simon, PhD)Contact: Principal Investigator (Martin Simon, PhD)Community based hemato-oncology medical office, Erlangen, Germany
Contact: Study coordinator (Michael J Eckart, PhD)Contact: Principal Investigator (Michael J Eckart, PhD)Community based hemato-oncology medical office, Frankfurt, Germany
Contact: Study coordinator (Wolfgang U Knauf, Prof PhD)Contact: Principal Investigator (Wolfgang U Knauf, Prof PhD)Krankenhaus Nordwest, Frankfurt, Germany
Contact: Study coordinator (Eckhart Weidmann, Prof PhD)Contact: Principal Investigator (Eckhart Weidmann, Prof PhD)Community based hemato-oncology medical office, Freiburg im Breisgau, Germany
Contact: Study coordinator (Matthias Zaiss, PhD)Contact: Principal Investigator (Matthias Zaiss, PhD)Community based hemato-oncology medical office, Friedrichshafen, Germany
Contact: Study coordinator (Helmut Oettle, PhD)Contact: Principal Investigator (Helmut Oettle, PhD)Community based hemato-oncology medical office, Fürth, Germany
Contact: Study coordinator (Harald Wagner, PhD)Contact: Principal Investigator (Harald Wagner, PhD)Community based hemato-oncology medical office, Germering, Germany
Contact: Study coordinator (Johann Mittermüller, PhD)Contact: Principal Investigator (Johann Mittermüller, PhD)Community based hemato-oncology medical office, Giessen, Germany
Contact: Study coordinator (Georg Ch Schließer, PhD)Contact: Principal Investigator (Georg Ch Schließer, PhD)University Clinic | Medicinal Clinic IV, Giessen, Germany
Contact: Study coordinator (Mathias J Rummel, Prof. Dr.) · mathias.rummel@innere.med.uni-giessen.de · +4964198542Contact: Principal Investigator (Mathias J Rummel, Prof. Dr.)St.-Marien-Hospital, Hagen, Germany
Contact: Study coordinator (H W Lindemann, PhD)Contact: Principal Investigator (H W Lindemann, PhD)Community based hemato-oncology medical office, Halle, Germany
Contact: Study coordinator (Robert Rohrberg, PhD)Contact: Principal Investigator (Robert Rohrberg, PhD)Evangelisches Krankenhaus, Hamm, Germany
Contact: Study coordinator (Jörg Schubert, Prof PhD)Contact: Principal Investigator (Jörg Schubert, Prof PhD)Community based hemato-oncology medical office, Hanau, Germany
Contact: Study coordinator (Gerd Lautenschläger, PhD)Contact: Principal Investigator (Gerd Lautenschläger, PhD)Community based hemato-oncology medical office, Heidelberg, Germany
Contact: Study coordinator (Stefan Fuxius, PhD)Contact: Principal Investigator (Stefan Fuxius, Phd)Community based hemato-oncology medical office, Herne, Germany
Contact: Study coordinator (Lars Hahn, PhD)Contact: Principal Investigator (Lars Hahn, PhD)Marienkrankenhaus, Herne, Germany
Contact: Study coordinator (Dirk Strumberg, Prof PhD)Contact: Principal Investigator (Dirk Strumberg, Prof PhD)Community based hemato-oncology medical office, Homberg (Ohm), Germany
Contact: Study coordinator (Wolfgang Weber, PhD)Contact: Principal Investigator (Wolfgang Weber, PhD)Community based hemato-oncology medical office, Kaiserslautern, Germany
Contact: Study coordinator (Manfred Reeb, PhD)Contact: Principal Investigator (Manfred Reeb, PhD)Städtisches Klinikum, Karlsruhe, Germany
Contact: Study coordinator (Martin Bentz, Prof. PhD)Contact: Principal Investigator (Martin Bentz, Prof. PhD)Community based hemato-oncology medical office, Kassel, Germany
Contact: Study coordinator (Ulrike Söling, PhD)Contact: Principal Investigator (Ulrike Söling, PhD)Klinikum Kempten-Oberallgäu, Kempten, Germany
Contact: Study coordinator (Otto Prümmer, PhD)Contact: Principal Investigator (Otto Prümmer, PhD)Community based hemato-oncology medical office, Koblenz, Germany
Contact: Study coordinator (Rudolf Weide, Prof PhD)Contact: Principal Investigator (Rudolf Weide, Prof PhD)Community based hemato-oncology medical office, Krefeld, Germany
Contact: Study coordinator (Michael Neise, PhD)Contact: Principal Investigator (Michael Neise, PhD)Community based hemato-oncology medical office, Kronach, Germany
Contact: Study coordinator (Martina Stauch, PhD)Contact: Principal Investigator (Stauch Martina, PhD)Community based hemato-oncology medical office, Landau, Germany
Contact: Study coordinator (Eva Huntenburg, PhD)Contact: Principal Investigator (Eva Huntenburg, PhD)Community based hemato-oncology medical office, Landshut, Germany
Contact: Study coordinator (Ursula Vehling-Kaiser, PhD)Contact: Principal Investigator (Ursula Vehling-Kaiser, PhD)Community based hemato-oncology medical office, Landshut, Germany
Contact: Study coordinator (Barbara Kempf, PhD)Contact: Principal Investigator (Barbara Kempf, PhD)Klinikum Leverkusen GmbH, Leverkusen, Germany
Contact: Study coordinator (Norbert Niederle, Prof PhD)Contact: Principal Investigator (Norbert Niederle, Prof PhD)St. Marienkrankenhaus, Ludwigshafen, Germany
Contact: Study coordinator (H Weiss, Prof PhD)Contact: Principal Investigator (H Weiss, Prof PhD)Community based hemato-oncology medical office, Lüdenscheid, Germany
Contact: Study coordinator (Dietrich Kämpfe, PhD)Contact: Principal Investigator (Dietrich Kämpfe, PhD)Universitätsklinik Mainz, Mainz, Germany
Contact: Study coordinator (Georg Heß, PhD)Contact: Principal Investigator (Georg Heß, PhD)Community based hemato-oncology medical office, Marburg, Germany
Contact: Study coordinator (Christina Balser, PhD)Contact: Principal Investigator (Christina Balser, PhD)Community based hemato-oncology medical office, Mönchengladbach, Germany
Contact: Study coordinator (Ulrich Grabenhorst, PhD)Contact: Principal Investigator (Ulrich Grabenhorst, PhD)Community based hemato-oncology medical office, München, Germany
Contact: Study coordinator (Peter Bojko, PhD)Contact: Principal Investigator (Peter Bojko, PhD)University Clinic Großhadern, München, Germany
Contact: Study coordinator (Martin Dreyling, Prof PhD)Contact: Principal Investigator (Martin Dreyling, Prof PhD)Community based hemato-oncology medical office, Neumarkt, Germany
Contact: Study coordinator (Ekkehart Ladda, PhD)Contact: Principal Investigator (Ekkehart Ladda, PhD)Community based hemato-oncology medical office, Nuremberg, Germany
Contact: Study coordinator (Michael Schauer, PhD)Contact: Principal Investigator (Michael Schauer, PhD)Community based hemato-oncology medical office, Nuremberg, Germany
Contact: Study coordinator (Joachim Zimber, PhD)Contact: Principal Investigator (Joachim Zimber, PhD)St. Clemens Hospital, Oberhausen, Germany
Contact: Study coordinator (Jutta Schneider, PhD)Contact: Principal Investigator (Jutta Schneider, PhD)St. Martinus-Hospital, Olpe, Germany
Contact: Study coordinator (Clemens Müller-Naendrup, PhD)Contact: Principal Investigator (Clemens Müller-Naendrup, PhD)Community based hemato-oncology medical office, Osnabrück, Germany
Contact: Study coordinator (Gertrud Lenzen, PhD)Contact: Principal Investigator (Gertrud Lenzen, PhD)St. Josefs-Krankenhaus, Potsdam, Germany
Contact: Study coordinator (Michael Göner, PhD)Contact: Principal Investigator (Michael Göner, PhD)Community based hemato-oncology medical office, Rehling, Germany
Contact: Study coordinator (Stephan Hochdörfer, PhD)Contact: Principal Investigator (Stephan Hochdörfer, PhD)Community based hemato-oncology medical office, Rüsselsheim am Main, Germany
Contact: Study coordinator (Michael Baldus, Phd)Contact: Principal Investigator (Michael Baldus, Phd)Caritas Klinik St. Theresia, Saarbrücken, Germany
Contact: Study coordinator (Axel Matzdorff, Prof PhD)Contact: Principal Investigator (Axel Matzdorff, Prof PhD)Community based hemato-oncology medical office, Schkeuditz, Germany
Contact: Study coordinator (Thomas Edelmann, PhD)Contact: Principal Investigator (Thomas Edelmann, PhD)Kreiskrankenhaus Schotten, Schotten, Germany
Contact: Study coordinator (M Graubner, PhD)Contact: Principal Investigator (M Graubner, PhD)Community based hemato-oncology medical office, Schweinfurt, Germany
Contact: Study coordinator (Reginhard von Hirschhausen, PhD)Contact: Principal Investigator (Reginhard von Hirschhausen, PhD)Community based hemato-oncology medical office, Siegen, Germany
Contact: Study coordinator (F A Trux, PhD)Contact: Principal Investigator (F A Trux, PhD)St.-Marien-Krankenhaus, Siegen, Germany
Contact: Study coordinator (Winfried Gassmann, PhD)Contact: Principal Investigator (Winfried Gassmann, PhD)Diakonie - Klinikum Stuttgart, Stuttgart, Germany
Contact: Study coordinator (Else Heidemann, Prof PhD)Contact: Principal Investigator (Else Heidemann, Prof. PhD)Community based hemato-oncology medical office, Trier, Germany
Contact: Study coordinator (Hans P Laubenstein, PhD)Contact: Principal Investigator (Hans P Laubenstein, PhD)Community based hemato-oncology medical office, Tübingen, Germany
Contact: Study coordinator (Swen H Jacki, PhD)Contact: Principal Investigator (Swen H Jacki, PhD)University Clinic Ulm, Ulm, Germany
Contact: Study coordinator (Christian Buske, Prof PhD)Contact: Principal Investigator (Christian Buske, Prof PhD)Städtisches Krankenhaus Villingen, Villingen-Schwenningen, Germany
Contact: Study coordinator (Wolfram Brugger, Prof PhD)Contact: Principal Investigator (Wolfram Brugger, Prof. PhD)Community based hemato-oncology medical office, Weilheim, Germany
Contact: Study coordinator (Michael Sandherr, PhD)Contact: Principal Investigator (Michael Sandherr, PhD)Sophien- und Hufeland Klinikum, Weimar, Germany
Contact: Study coordinator (Thomas Hoffmann, Phd)Contact: Principal Investigator (Thomas Hoffmann, PhD)Asklepios Nordseeklinik, Westerland, Germany
Contact: Study coordinator (Willy Nettekoven, PhD)Contact: Principal Investigator (Willy Nettekoven, PhD)Community based hemato-oncology medical office, Wiesbaden, Germany
Contact: Study coordinator (Klaus M Josten, PhD)Contact: Principal Investigator (Klaus M Josten, PhD)Dr. Horst-Schmidt-Kliniken, Wiesbaden, Germany
Contact: Study coordinator (Norbert Frickhofen, Prof PhD)Contact: Principal Investigator (Norbert Frickhofen, Prof PhD)Community based hemato-oncology medical office, Wilhelmshaven, Germany
Contact: Study coordinator (Yolanda Rodemer, PhD)Contact: Principal Investigator (Yolanda Rodemer, PhD)Community based hemato-oncology medical office, Wolfsburg, Germany
Contact: Study coordinator (Joachim Haessner, PhD)Contact: Principal Investigator (Joachim Haessner, PhD)
מובילי המחקר
Mathias J Rummel, Prof. Dr.
Principal Investigator
Justus-Liebig-University | University Hospital | Medicinal Clinic IV